Global, Regional, and National Burdens Attributable to Drug Use Across 204 Countries and Territories Between 1990 and 2021: The Global Burden of Disease Study 2021 [0.03%]
204个国家和 territories 1990至2021年药物使用造成的疾病和伤害负担：全球疾病负担研究2021
Xinsheng Wu,Thomas Fitzpatrick,Guozhen Wu et al.
Xinsheng Wu et al.
Objectives: Diseases, injuries, and death attributable to drug use are a major global public health problem. Methods: This was a cross-...
A Novel Intravenous Buprenorphine Micro-Infusion Strategy: Application in Critical Care and Opioid Use Disorder [0.03%]
一种新型的静脉美沙酮微输注策略的应用——在重症监护和阿片类药物使用障碍中的应用
David K Carroll,Andrew King,Brandtly Yakey et al.
David K Carroll et al.
Objectives: Buprenorphine (BUP), a partial mu-opioid receptor (MOR) agonist, is an effective analgesic and is standard-of-care for treating opioid use disorder (OUD). Transitioning from full MOR agonists to stable BUP dos...
Extended-release Buprenorphine for Opioid Use Disorder in Hospital and Emergency Department Settings [0.03%]
医院和急诊科使用缓释布洛芬丁治疗阿片类药物使用障碍
Megan Heeney,Erik Anderson,Lauren Roller Sirey et al.
Megan Heeney et al.
Objectives: Hospitalization and emergency department (ED) visits are an underutilized opportunity to reach high-risk patients with opioid use disorder (OUD) with buprenorphine (BUP) treatment and reduce the ongoing and wi...
Illicit Fentanyl Exposures in Cats and Dogs Reported to a North American Veterinary Poison Control Center From 2019 to 2023 [0.03%]
2019至2023年北美一家动物毒物控制中心报告的猫和狗接触非法芬太尼的情况
Orrin D Ware,Ginger Watts Brown
Orrin D Ware
Objectives: As a prominent concern for addiction medicine, illicit fentanyl and its analogues have been implicated in numerous poisonings among people. Many households in Canada and the United States include cats or dogs ...
Evaluating the Impact of Low Threshold Bridge Clinic Expansion on Equitable Access to Substance Use Disorder Treatment [0.03%]
评估低门槛桥梁门诊扩展对 substance use disorder治疗公平获取的影响
Eugene Lambert,Jasmine Irvin,Susan Regan et al.
Eugene Lambert et al.
Objectives: Racial inequities in substance use disorder treatment, and specifically buprenorphine treatment, contribute to overdose inequities. Bridge Clinics are a low-threshold, transitional treatment model that may imp...
Naltrexone in the Treatment of Ketamine Use Disorders: A Case Report and Literature Review [0.03%]
纳曲酮治疗氯胺酮成瘾的个案报告及文献综述
Rishi Verma,Tom Colley,Claire Waldock et al.
Rishi Verma et al.
Background: Nonprescribed use of ketamine has increased worldwide due to its hallucinogenic and psychedelic effects. Ketamine use disorders (KUDs) are marked by intense cravings and tolerance, which often trigger relapses...
Trends in Newly Filled GLP-1 Receptor Agonist Prescriptions for US Patients With Versus Without Comorbid Alcohol Use Disorder, 2016-2024 [0.03%]
2016至2024年美国伴或不伴酒精使用障碍的患者新开胰高血糖素样肽-1受体激动剂处方趋势
Joshua D Wallach,Stephanie S O&#x;Malley,Kasia J Lipska et al.
Joshua D Wallach et al.
Objectives: To evaluate trends in newly filled GLP-1 receptor agonist (GLP-1RA) prescriptions among U.S. adults with type 2 diabetes (T2DM) and/or obesity, comparing those with and without comorbid alcohol use disorder (A...
Experiences With Substance Use Disorder Treatment and the Role of Social Norms in the Asian American Pacific Islander Community: A Qualitative Study [0.03%]
亚洲太平洋岛裔美国人社区物质使用障碍治疗经历及社会规范的作用：定性研究
Warren Yamashita,Jessica As Wang,Gael Perez et al.
Warren Yamashita et al.
Objectives: The Asian American Pacific Islander (AAPI) community accesses substance use disorder (SUD) services less frequently and at more advanced stages compared with the general population. Understanding experiences o...
Estimated Hospital Cost Reduction Following Implementation of Hospital-dispensed Discharge Methadone [0.03%]
医院开处美沙酮出院处方以降低再入院率及减少住院费用的成本估算
Susan L Calcaterra,Yevgeniya Jenny Scherbak,Julie Nickell et al.
Susan L Calcaterra et al.
Objectives: US regulatory changes now allow practitioners to dispense up to a 3-day supply of methadone from the inpatient pharmacy at hospital dishcarge at one time. We characterized outcomes related to hospital-dispense...
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine [0.03%]
芬太尼中添加物质的变化：从扎来普隆到美托咪idine
Samantha Huo,Jeanmarie Perrone
Samantha Huo
Medetomidine has been increasingly found in the illegal opioid supply across the country over the last few years. In 2024, it replaced xylazine as the most common adulterant of the illegal opioid supply in the Philadelphia area. Medetomidin...